SPARC — Sun Pharma Advanced Research Co Balance Sheet
0.000.00%
- IN₹53.84bn
- IN₹56.48bn
- IN₹717.70m
Annual balance sheet for Sun Pharma Advanced Research Co, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 157 | 157 | 4,066 | 1,571 | 43.2 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 385 | 519 | 439 | 1,060 | 162 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 598 | 712 | 4,550 | 2,694 | 262 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 951 | 951 | 1,073 | 1,086 | 993 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 2,297 | 2,801 | 8,301 | 5,150 | 3,355 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2,334 | 1,714 | 1,789 | 2,651 | 3,742 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 3,979 | 2,489 | 3,174 | 3,893 | 5,525 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -1,683 | 312 | 5,128 | 1,258 | -2,170 |
Total Liabilities & Shareholders' Equity | 2,297 | 2,801 | 8,301 | 5,150 | 3,355 |
Total Common Shares Outstanding |